Focus Stocks
Sanofi-Aventis Is Near its 200 Day Moving Average
Published on Wednesday, 18 July 2012 07:44 Written by TradersHuddle Wire
New York, July 18th (TradersHuddle.com) -Sanofi-Aventis (NYSE:SNY) closed the trading session at $37.64 near its 200 day moving average set at $36.00. Sanofi-Aventis' price action is just above this key support level, grabbing traders' attention for a possible trading opportunity.
Sanofi-Aventis (NYSE:SNY) is a global pharmaceutical company that researches, develops and manufactures prescription pharmaceuticals and vaccines. The Company develops cardiovascular, thrombosis, metabolic disorder, central nervous system, internal medicine and oncology drugs, and vaccines.
The latest price action range, defined by a peaks and troughs algorithm, places calculated support at $33.03 and resistance at $38.41. These levels will provide insight for the stock's latest price dynamics.
Traders wanting to establish a position on Sanofi-Aventis will look for evidence of buying near the 200 day moving average, before opening the position as close as possible to this key technical level. Also, they need to consider the latest range defined by the calculated support and resistance levels for insights on other key levels that might have an effect on future price movements.
Related Articles
- Critical Alerts For Sanofi, Salesforce.com, AFLAC, HCA Holdings, and Silver Wheaton Released By InvestorsObserver
- Sanofi-Aventis Is Close to the 50 Day Moving Average
- Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine
- Approaching Resistance: Sanofi-Aventis
- Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis
- Football Legend Jerome Bettis & Sanofi US Tackle Anaphylaxis During National Asthma and Allergy Awareness Month
- Reference Points for Sanofi-Aventis
- Sanofi and Regeneron Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA)
- Approaching Resistance: Sanofi-Aventis
- Sanofi-Aventis Is Close to Resistance
Related Partner Headlines
- Sanofi Stock Buy Recommendation Reiterated (SNY) - TheStreet.com
- Sanofi (SNY): Today's Featured Drugs Laggard - TheStreet.com
- Zalicus Prednisporin Licensee Sanofi Provides Update on Development Status - Benzinga
- Sanofi Stock Buy Recommendation Reiterated (SNY) - TheStreet.com
- Sanofi Reaches New 52-Week High (SNY) - TheStreet.com
- Sanofi Stock Buy Recommendation Reiterated (SNY) - TheStreet.com
- Sanofi To Buy Genfar - Benzinga
- Sanofi Stock Buy Recommendation Reiterated (SNY) - TheStreet.com
- Sanofi (SNY): Today's Featured Health Care Laggard - TheStreet.com
- Sanofi Reaches New 52-Week High (SNY) - TheStreet.com
TradersHuddle Search
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Dow Today: Verizon Communications (VZ) Higher - TheStreet.com -
Separating the Bargains From the Busts - TheStreet.com -
Cramer Quick Take: The 60-Inch TV Will Be Key This Holiday - TheStreet.com -
Cramer Quick Take: Cisco Wins If Fiscal Cliff Is Resolved - TheStreet.com -
Gap Up and Sit - TheStreet.com -
Apple, Intel, MicroStrategy: Tech Winners & Losers - TheStreet.com -
Windows 8 PC Sales Disappointing: Report - TheStreet.com -
Cramer Quick Take: Buy Home Depot and Lowe's - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:15,357.01 Trade time:2:57PM EDT Value change:▼30.57 (-0.20%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,660.42 Trade time:2:57PM EDT Value change:▼8.74 (-0.52%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:3,471.92 Trade time:2:57PM EDT Value change:▼30.20 (-0.86%)In The Wires
-
Network-1 Announces Acquisition Of Patent Portfolio From Mirror Worlds -
Bankers Petroleum announces annual meeting voting results and election of directors -
Comcast Awards $82,000 In Scholarships To 73 New Jersey High School Seniors -
Perpetual Energy Inc. announces election of directors -
comScore Releases April 2013 U.S. Online Video Rankings -
IMRIS Announces US Patent for Microsurgical Robot Concept -
Saker Aviation Services, Inc. Announces New Financing -
American Capital Energy & Infrastructure Expands Investment Team, Appoints Senior Advisors








